Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
3.1 USD | -9.62% | -14.13% | -24.02% |
Mar. 28 | Transcript : Aspira Women's Health Inc., Q4 2023 Earnings Call, Mar 28, 2024 | |
Mar. 28 | Earnings Flash (AWH) ASPIRA WOMEN'S HEALTH Posts Q4 Revenue $2.1M | MT |
Financials (USD)
Sales 2023 | 9.15M | Sales 2024 * | 10.94M | Capitalization | 36.29M |
---|---|---|---|---|---|
Net income 2023 | -16M | Net income 2024 * | -16M | EV / Sales 2023 | 4.61 x |
Net cash position 2023 * | - | Net cash position 2024 * | - | EV / Sales 2024 * | 3.32 x |
P/E ratio 2023 |
-2.25
x | P/E ratio 2024 * |
-2.5
x | Employees | 85 |
Yield 2023 * |
-
| Yield 2024 * |
-
| Free-Float | 57.54% |
Latest transcript on Aspira Women's Health Inc.
1 day | -9.62% | ||
1 week | -14.13% | ||
Current month | -21.52% | ||
1 month | -19.48% | ||
3 months | -24.76% | ||
6 months | -40.61% | ||
Current year | -24.02% |
Managers | Title | Age | Since |
---|---|---|---|
Nicole Sandford
CEO | Chief Executive Officer | 54 | 21-02-21 |
Torsten Hombeck
DFI | Director of Finance/CFO | 55 | 23-06-14 |
Tatiana Black
CMP | Compliance Officer | - | - |
Members of the board | Title | Age | Since |
---|---|---|---|
Ellen Vos
BRD | Director/Board Member | 68 | 23-05-08 |
Director/Board Member | 60 | 23-05-08 | |
Jannie Herchuk
CHM | Chairman | - | 23-05-08 |
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
0.00% | 2 M€ | -.--% |
Date | Price | Change | Volume |
---|---|---|---|
24-03-28 | 3.1 | -9.62% | 38,687 |
24-03-27 | 3.43 | -2.00% | 24,759 |
24-03-26 | 3.5 | -1.69% | 21,458 |
24-03-25 | 3.56 | -2.47% | 19,172 |
24-03-22 | 3.65 | +1.11% | 14,010 |
Delayed Quote Nasdaq, March 28, 2024 at 04:30 pm EDT
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-24.02% | 36.29M | |
-6.65% | 12.54B | |
+82.29% | 4.14B | |
-14.23% | 2.34B | |
-23.73% | 2.51B | |
-19.45% | 1.66B | |
+32.37% | 1.15B | |
+7.42% | 840M | |
-11.75% | 548M | |
-34.49% | 466M |